KA

Kabeer Aziz

Partner at Adjuvant Capital

New York, New York

Overview 

Kabeer Aziz is a Co-founder and Partner at Adjuvant Capital in New York, with a background in investment and finance, having worked at Global Health Investment Fund and Metalmark Capital. He has successfully invested in companies like Minervax, LimmaTech Biologics, and Pulmocide, contributing to the growth of the healthcare and biotech sectors. Aziz's career highlights include his role as a Partner at Adjuvant Capital, where he focuses on investing in various sectors such as diagnostics, medical devices, pharmaceuticals, and biotech, and his previous experience at Global Health Investment Fund, Metalmark Capital, and Greenhill & Co. as an Analyst.

Work Experience 

  • Partner

    2018 - Current

    Leading life sciences investment fund focused on global public health

Adjuvant Capital is a life sciences investment firm focused on global health.

  • Director

    2019

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

Raised $162,000,000.00 from Bill & Melinda Gates Foundation and Bill & Melinda Gates Foundation.

  • Director

    2020

  • Director

    2021

  • Board Observer

    2022

  • Director

    2024

ChromaCode is a molecular diagnostics company focusing on bioinformatics.

Raised $93,967,513.00 from Global Brain Corporation.

  • Director

    2021 - 2023

  • Board Observer

    2018 - 2020

  • Senior Associate

    2015 - 2018

    Impact investing to finance global health research & development

Articles About Kabeer

Relevant Websites